{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:10:13Z","timestamp":1778721013688,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/18\/1\/503931 & IA\/CRC\/19\/1\/610005"],"award-info":[{"award-number":["IA\/CPHI\/18\/1\/503931 & IA\/CRC\/19\/1\/610005"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CRC\/19\/1\/610005"],"award-info":[{"award-number":["IA\/CRC\/19\/1\/610005"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jad.2023.10.052","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:46:22Z","timestamp":1697600782000},"page":"617-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Is ECT effective in treatment-refractory OCD? Concerns with the data and analysis of a recently published randomized-controlled trial"],"prefix":"10.1016","volume":"344","author":[{"given":"Shyam Sundar","family":"Arumugham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadisha","family":"Thirthalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.C. Janardhan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.10.052_bb0005","doi-asserted-by":"crossref","DOI":"10.3768\/rtipress.2009.mr.0009.0903","article-title":"A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values","author":"Chakraborty","year":"2009"},{"key":"10.1016\/j.jad.2023.10.052_bb0010","series-title":"The ECT Handbook","first-page":"183","article-title":"Practical aspects of ECT","author":"Dunne","year":"2019"},{"key":"10.1016\/j.jad.2023.10.052_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.10.052_bb0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4088\/JCP.14r09129","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review","volume":"76","author":"Fontenelle","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.10.052_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pnpbp.2005.08.017","article-title":"The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients","volume":"30","author":"Gonul","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.10.052_bb0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry","volume":"61","author":"Gueorguieva","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.10.052_bb0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jad.2021.10.005","article-title":"Effect of modified electroconvulsive therapy on neuro metabolites and magnetic resonance spectroscopy imaging signals in patients with refractory obsessive-compulsive disorder","volume":"296","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.10.052_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","article-title":"The role of electroconvulsive therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2023.10.052_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.2014.885504","article-title":"Clinically relevant interactions between newer antidepressants and second-generation antipsychotics","volume":"10","author":"Spina","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jad.2023.10.052_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","article-title":"Clinical practice guidelines for the use of electroconvulsive therapy","volume":"65","author":"Thirthalli","year":"2023","journal-title":"Indian J. Psychiatry."},{"key":"10.1016\/j.jad.2023.10.052_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0004867419839139","article-title":"Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy","volume":"53","author":"Weiss","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723012351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723012351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:31:46Z","timestamp":1778718706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723012351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":11,"alternative-id":["S0165032723012351"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.10.052","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is ECT effective in treatment-refractory OCD? Concerns with the data and analysis of a recently published randomized-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}